Oral formulations of L-dopa and continuous dopaminergic stimulation

Mov Disord. 2012 Apr;27(4):579. doi: 10.1002/mds.24953. Epub 2012 Feb 16.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antiparkinson Agents / therapeutic use*
  • Carbidopa / therapeutic use*
  • Dopamine Agents / administration & dosage*
  • Drug Delivery Systems*
  • Female
  • Humans
  • Levodopa / administration & dosage*
  • Levodopa / therapeutic use*
  • Male
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Dopamine Agents
  • Levodopa
  • Carbidopa